Valnoctamide as a valproate substitute with low teratogenic potential: Double-blind controlled clinical trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Valnoctamide (Primary)
- Indications Mania; Schizoaffective disorder
- Focus Therapeutic Use
- 25 Nov 2009 Biomarkers information updated
- 26 May 2008 The completion date for this trial is May 2008 as reported by ClinicalTrials.gov.
- 26 May 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.